KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Biocryst Pharmaceuticals (BCRX) Asset Utilization Ratio (2023 - 2025)

Biocryst Pharmaceuticals' Asset Utilization Ratio history spans 8 years, with the latest figure at 0.98 for Q4 2025.

  • For Q4 2025, Asset Utilization Ratio rose 6.34% year-over-year to 0.98; the TTM value through Dec 2025 reached 0.98, up 6.34%, while the annual FY2025 figure was 1.74, 94.64% up from the prior year.
  • Asset Utilization Ratio reached 0.98 in Q4 2025 per BCRX's latest filing, down from 1.33 in the prior quarter.
  • In the past five years, Asset Utilization Ratio ranged from a high of 1.34 in Q3 2024 to a low of 0.02 in Q3 2023.
  • Average Asset Utilization Ratio over 3 years is 0.8, with a median of 0.95 recorded in 2024.
  • Peak YoY movement for Asset Utilization Ratio: soared 6307.16% in 2024, then fell 0.72% in 2025.
  • A 3-year view of Asset Utilization Ratio shows it stood at 0.63 in 2023, then skyrocketed by 46.82% to 0.92 in 2024, then rose by 6.34% to 0.98 in 2025.
  • Per Business Quant, the three most recent readings for BCRX's Asset Utilization Ratio are 0.98 (Q4 2025), 1.33 (Q3 2025), and 1.19 (Q2 2025).